… In addition, PEGylated human interferon lambda-1 (PEG-IFN-λ-1a) potently delayed
SARS-CoV-2 replication in epithelial cells, and prophylactic (pre-exposure) or therapeutic …

… could be promising prophylactic therapeutics for COVID-19. … as a promising prophylactic,
therapeutic candidate for COVID-19. … be a potential prophylactic therapeutic for COVID-19 in the …

… This article outlines the prophylaxis therapeutic potential of supplements vitamins and
micronutrients in COVID-19. By ameliorating the inflammatory and oxidative stress associated with …

… including a group of older people affected by COVID-19, we reported no difference in terms
of mortality between subjects taking a prophylactic or therapeutic dose of LMWH. This finding …

… In this randomized, open-label, phase II study, we randomized COVID-19 patients
requiring mechanical ventilation to receive either therapeutic enoxaparin or the standard …

… Whether therapeutic anticoagulation improves outcomes in patients hospitalised … COVID-19
is unknown. We aimed to compare the efficacy and safety of therapeutic versus prophylactic …

… This section enumerates the various therapeutic agents along … therapeutic strategies for the
management of COVID-19/SARS… prophylactic options that may be followed in case of COVID-…

… Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19
and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, …

… Anticoagulation in hospitalized COVID-19 patients has been … -to-therapeutic versus
prophylactic anticoagulation for … patient-centered secondary outcomes in COVID-19 patients. …

… syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS…
-2 underlying the current coronavirus disease 2019 (COVID-19) pandemic, eyes naturally …